All Terrain Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

All Terrain Financial Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-601	Closed	-$58K	–	245
2018 Q3	$58K	Buy	+601	New	+$58.3K	0.02%	209
2018 Q2	–	Sell	-1,200	Closed	-$105K	–	258
2018 Q1	$105K	Buy	+1,200	New	+$110K	0.05%	187

Other funds holding XBI

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

All Terrain Financial Advisors's XBI Position: Q4 2018 in Review

All Terrain Financial Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2018, closing a stake of 601 shares — an estimated $58K sold.

All Terrain Financial Advisors first reported a position in XBI in Q1 2018 and held it in 2 quarters. The position peaked at $105K in Q1 2018. 427 funds tracked by Wall St. Rank hold XBI as of Q4 2018.

All Terrain Financial Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2018 after selling out during the quarter.
All Terrain Financial Advisors sold 601 State Street SPDR S&P Biotech ETF shares in Q4 2018, an estimated $58K.
All Terrain Financial Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and held it in 2 quarters.
All Terrain Financial Advisors's State Street SPDR S&P Biotech ETF position peaked at $105K in Q1 2018.
427 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2018.

Based on All Terrain Financial Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.